Kim, HL Lab
Cancer immunotherapies have the potential to target tumors while sparing normal tissue. We are seeking strategies to stimulate the immune system to generate anticancer responses. We are also seeking biomarkers that can help determine prognosis and treatment response. Our goal is to develop novel treatment strategies that can be tested in laboratory models and clinical trials.
Personal Statement
Every day I see the devastating effects of cancer on patients and their families. Our research goal is simple: working every day looking for new and better ways to find, prevent and treat cancers. We test new drugs and treatment approaches in cell lines and animal models. Laboratory observations are used to develop innovative clinical trials that give hope to cancer patients."
Hyung Kim, MD
Breakthrough Research
An important goal of our laboratory is to clarify the role of the immune system during cancer therapy. Standard systemic therapies have established antitumor properties; however, the immune modulating effect of traditional cytotoxic drugs and newer targeted agents has received less attention. Understanding the immune modulating properties of these agents paves the way for combination therapies that include novel cancer vaccines.
Laboratory Team
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Kim Lab, whose dedicated efforts lead to groundbreaking discoveries.
Job Opportunities
We are actively recruiting students and postdocs to be our colleagues and expand lab knowledge and expertise to make important breakthroughs.
Collaborations
The Kim Lab collaborates with a wide range of investigators within Cedars-Sinai and institutions around the world.
- Freeman Laboratory
- Li Laboratory
- Thompson Laboratory
- You Laboratory
Contact the Kim Lab
8700 Beverly Blvd.
Davis Building, Room 5094-D
Los Angeles, CA 90048